TARGETED-RELEASE BUDESONIDE (Kinpeygo®)

Clinical Indication

For treating Primary IgA Nephropathy

Comments

In line with NICE TA1128

Funding: 4th May 2026

Date of classification

March 2024

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.